ALUMIS INC.
For the period ended Dec 31, 2025. Filed Mar 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 19, 2026
ALMS$6.55+8.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| | | | | | | |
|---|---|---|---|---|---|---|
| · · December 31, · · December 31, | ||||||
| (in thousands, except share and per share amounts) · · 2025 · · 2024 | ||||||
| Assets · · · · | ||||||
| Current assets: · · · · | ||||||
| Cash and cash equivalents | | $89,670 | | $169,526 | ||
| Restricted cash | | 82 | | — | ||
| Marketable securities | | 218,831 | | 118,737 | ||
| Research and development prepaid expenses | | 2,909 | | 13,424 | ||
| Other prepaid expenses and current assets | | 6,740 | | 4,501 | ||
| Total current assets | | 318,232 | | 306,188 | ||
| Restricted cash, non-current | | 1,301 | | 1,106 | ||
| Property and equipment, net | | 18,190 | | 20,968 | ||
| Intangible assets | | | 50,959 | | | — |
| Operating lease right-of-use assets, net | | 16,971 | | 12,723 | ||
| Other assets, non-current | | 6,287 | | 7 | ||
| Total assets | | $411,940 | | $340,992 | ||
| Liabilities and Stockholders’ Equity | | | | | ||
| Current liabilities: | | | | | ||
| Accounts payable | | $10,106 | | $9,624 | ||
| Research and development accrued expenses | | 34,781 | | 29,149 | ||
| Deferred revenue, current | | | 1,458 | | | — |
| Other accrued expenses and current liabilities | | 22,303 | | 10,580 | ||
| Operating lease liabilities, current | | 4,670 | | 1,557 | ||
| Total current liabilities | | 73,318 | | 50,910 | ||
| Operating lease liabilities, non-current | | 32,244 | | 29,165 | ||
| Deferred revenue, non-current | | | 2,611 | | | — |
| Deferred tax liability | | | 2,140 | | | — |
| Share repurchase liability | | | 123 | | | 813 |
| Other liabilities, non-current | | 207 | | — | ||
| Total liabilities | | 110,643 | | 80,888 | ||
| Commitments and contingencies (Note 9) | | | | | ||
| Stockholders’ equity: | | | | | ||
| Preferred stock, $0.0001 par value; 50,000,000 shares authorized, zero shares issued and outstanding as of December 31, 2025 and December 31, 2024 | | | — | | | — |
| Common stock, voting, $0.0001 par value; 492,815,092 voting shares authorized as of December 31, 2025 and December 31, 2024; 99,084,365 and 47,222,419 voting shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | | 9 | | 4 | ||
| Common stock, non-voting, $0.0001 par value; 7,184,908 non-voting shares authorized as of December 31, 2025 and December 31, 2024; 5,622,408 and 7,184,908 non-voting shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | | | 1 | | | 1 |
| Additional paid-in capital | | 1,202,975 | | 918,610 | ||
| Accumulated other comprehensive income (loss) | | 188 | | 40 | ||
| Accumulated deficit | | (901,876) | | (658,551) | ||
| Total stockholders’ equity | | 301,297 | | 260,104 | ||
| Total liabilities and stockholders’ equity | | $411,940 | | $340,992 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.